Full Text View
Tabular View
No Study Results Posted
Related Studies
Vorinostat in Children
This study is currently recruiting participants.
Verified November 2012 by National Center for Tumor Diseases, Heidelberg
Study NCT01422499   Information provided by National Center for Tumor Diseases, Heidelberg

First Received on August 3, 2011.   Last Updated on November 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Leukemia
Lymphoma
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
zolinza/vorinostat
Additional drug interventions recognized in this trial
Vorinostat
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Histone Deacetylase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Center for Tumor Diseases, Heidelberg
University Hospital Heidelberg
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services